Key result
Proven nonlipid preventive therapies for coronary heart disease remain substantially underutilized in clinical practice.
Answers are grounded in this paper and cite their sources.
Widespread application of proven primary and secondary preventive strategies for coronary heart disease would result in substantial savings of life and health care dollars. Proven strategies (excluding lipid therapy) include quitting smoking, treating hypertension, physical activity, aspirin therapy, and appropriate use of anticoagulants, beta blockers, and angiotensin-converting enzyme inhibitors in survivors of myocardial infarction. Estrogen replacement therapy is currently under clinical investigation. Avoidance of obesity and tight control of diabetes are prudent interventions as yet unproved by clinical trials. Unfortunately, preventive strategies are frequently underutilized. The greatest challenge for preventive cardiology is to put into practice what we already know to prevent the development and progression of atherosclerosis.
No takes yet. Share an insight, caveat, or question.
David J. Maron (1996) conducted a review in coronary heart disease. Nonlipid primary and secondary prevention strategies (smoking cessation, hypertension treatment, physical activity, aspirin, anticoagulants, beta blockers, ACE inhibitors) was evaluated. Nonlipid preventive strategies—such as smoking cessation, blood pressure control, exercise, aspirin, beta-blockers, and ACE inhibitors—are proven for coronary heart disease but remain underutilized.
Synapse has enriched 10 related papers. Consider them for comparative context: